GGrantIndex
Sort

24,576 grants matching microbiome

Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir

$1,227,889
Rafick-Pierre Sekaly · Emory University · P01 · FY2025 · AI

Role of the human microbiota and probiotics

$1,227,486
Michael Otto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Untargeted Analysis Resource

$1,227,326
Manish Arora · Icahn School Of Medicine At Mount Sinai · U2C · FY2023 · ES

Engineered human intestinal organoids: a modular system to model enteric disease

$1,226,729
Vincent B Young · University Of Michigan At Ann Arbor · U19 · FY2015 · AI

Immunology of aging and immunotherapy of aging-associated diseases

$1,226,456
Arya Biragyn · National Institute On Aging · ZIA · FY2022 · AG

The MetaCyc and BioCyc Pathway/Genome Databases [SRI Proposal ECU 10-626]

$1,226,262
Peter D Karp · Sri International · R01 · FY2011 · GM

Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis

$1,225,995
Ramon Bataller · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AA

Effects of systemic and topical perturbations on human microbes

$1,225,978
Heidi Kong · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Pediatric Oncology Branch Behavioral Science Core

$1,225,916
John Glod · Division Of Basic Sciences - Nci · ZID · FY2022 · CA

Translational Research Center to Expedite Novel Therapies in Cystic Fibrosis

$1,225,520
Bonnie W Ramsey · Seattle Children'S Hospital · P30 · FY2015 · DK

Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

$1,225,259
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2018 · DK

Regulators of Food Intake

$1,225,214
Jonathan Krakoff · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

A Phase II Controlled Trial of Allogeneic Mesenchymal Stromal Cells for the Treatment of Refractory Lupus (MiSLE)

$1,225,013
Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2024 · AI

INNATE AND ADAPTIVE IMMUNITY IN IBD

$1,224,994
Charles O Elson · University Of Alabama At Birmingham · P01 · FY2013 · DK

TARGETING THE GUT MICROBIOME TO TREAT POST TRAUMATIC OSTEOARTHRITIS

$1,224,983
The Regents Of The University Of Colorado · · FY2019 · Defense Health Agency

DartCF: The Dartmouth Cystic Fibrosis Research Center

$1,224,158
Dean R Madden · Dartmouth College · P30 · FY2020 · DK

Administrative Core

$1,224,113
Joseph Frank Petrosino · Baylor College Of Medicine · U19 · FY2024 · AI

Intestinal bacterial metagenome in pediatric NAFLD

$1,222,814
Nita H Salzman · Medical College Of Wisconsin · R01 · FY2016 · DK

Pharmacogenetic Studies

$1,222,415
Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir

$1,219,661
Rafick-Pierre Sekaly · Emory University · P01 · FY2024 · AI

OPTIMIZE - CCC - Lead Application

$1,219,588
Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2016 · HL

Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

$1,219,441
Ramnik J Xavier · Massachusetts General Hospital · P30 · FY2020 · DK

Center for Molecular Studies in Digestive and Liver Diseases

$1,218,750
Gary D. Wu · University Of Pennsylvania · P30 · FY2024 · DK

Center for Molecular Studies in Digestive and Liver Diseases

$1,218,750
Gary D. Wu · University Of Pennsylvania · P30 · FY2023 · DK

Center for Molecular Studies in Digestive and Liver Diseases

$1,218,750
Ken Hashigiwa Cadwell · University Of Pennsylvania · P30 · FY2025 · DK